Insider Buying: First Advantage Co. (NYSE:FA) CFO Buys 1,000 Shares of Stock

First Advantage Co. (NYSE:FA) CFO Steven Irwin Marks acquired 1,000 shares of the stock in a transaction dated Friday, March 7th. The shares were bought at an average cost of $13.50 per share, with a total value of $13,500.00. Following the transaction, the chief financial officer now directly owns 20,189 shares of the company’s stock, valued at $272,551.50. This represents a 5.21 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

First Advantage Stock Performance

NYSE FA opened at $13.05 on Tuesday. The firm has a 50-day moving average of $17.95 and a 200-day moving average of $18.68. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.85 and a current ratio of 3.85. The stock has a market cap of $2.26 billion, a PE ratio of 435.00 and a beta of 1.21. First Advantage Co. has a 52-week low of $12.90 and a 52-week high of $20.79.

Institutional Trading of First Advantage

A number of hedge funds have recently modified their holdings of the stock. Summit Investment Advisors Inc. lifted its stake in shares of First Advantage by 15.3% during the 4th quarter. Summit Investment Advisors Inc. now owns 6,267 shares of the company’s stock worth $117,000 after buying an additional 832 shares during the last quarter. Advisory Research Inc. raised its stake in First Advantage by 0.6% in the 4th quarter. Advisory Research Inc. now owns 212,446 shares of the company’s stock worth $3,979,000 after purchasing an additional 1,216 shares in the last quarter. Corebridge Financial Inc. raised its stake in First Advantage by 9.6% in the 4th quarter. Corebridge Financial Inc. now owns 29,784 shares of the company’s stock worth $558,000 after purchasing an additional 2,607 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in First Advantage by 17.6% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 19,626 shares of the company’s stock worth $368,000 after purchasing an additional 2,938 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in First Advantage by 9.0% in the 3rd quarter. Victory Capital Management Inc. now owns 39,510 shares of the company’s stock worth $784,000 after purchasing an additional 3,249 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Barclays decreased their target price on shares of First Advantage from $22.00 to $20.00 and set an “overweight” rating for the company in a research report on Friday, February 28th. William Blair reaffirmed an “outperform” rating on shares of First Advantage in a research report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of First Advantage in a research report on Wednesday, November 13th. BMO Capital Markets decreased their target price on shares of First Advantage from $24.00 to $22.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $22.00 target price on shares of First Advantage in a research report on Thursday, January 23rd. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $53.29.

About First Advantage

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.